ADULTS PATIENTS HAVING NON SEVERE HLH

Clinical trials for ADULTS PATIENTS HAVING NON SEVERE HLH explained in plain language.

Never miss a new study

Get alerted when new ADULTS PATIENTS HAVING NON SEVERE HLH trials appear

Sign up with your email to follow new studies for ADULTS PATIENTS HAVING NON SEVERE HLH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug trial offers hope for rare, overactive immune disease

Disease control Completed

This study tested whether a drug called itacitinib could help adults with a non-severe form of hemophagocytic lymphohistiocytosis (HLH), a rare and serious condition where the immune system becomes dangerously overactive. The goal was to see if itacitinib could control the diseas…

Matched conditions: ADULTS PATIENTS HAVING NON SEVERE HLH

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ADULTS PATIENTS HAVING NON SEVERE HLH

Get alerted when new ADULTS PATIENTS HAVING NON SEVERE HLH trials appear

New drug trial offers hope for rare, overactive immune disease